141
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections

&
Pages 1323-1334 | Published online: 29 Apr 2019

References

  • Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429–450. doi:10.1016/S0039-6257(05)80054-27660300
  • Erie JC, Campbell RJ, Liesegang TJ. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology. 1986;93:176–183. doi:10.1016/S0161-6420(86)33764-33951824
  • Yousef YA, Finger PT. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology. 2012;119:233–240. doi:10.1016/j.ophtha.2011.08.00522189448
  • Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health. 2013;18:1424–1443. doi:10.1111/tmi.1220324237784
  • Ong SS, Vora GK, Gupta PK. Anterior segment imaging in ocular surface squamous neoplasia. J Ophthalmol. 2016;2016:5435092. doi:10.1155/2016/543509227800176
  • Nanji AA, Sayyad FE, Galor A, Dubovy S, Karp CL. High-resolution Fourier-domain optical coherence tomography as an adjunctive tool in the diagnosis of corneal and conjunctival pathology. Ocul Surf. 2015;13:226–235. doi:10.1016/j.jtos.2015.02.00126045235
  • Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49:3–24. doi:10.1016/j.survophthal.2003.10.00814711437
  • Gichuhi S, Macharia E, Kabiru J, et al. Fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2016;4(6):e378–e385. doi:10.1016/S2214-109X(16)30052-327198842
  • Bahrami B, Greenwell T, Muecke JS. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment ofsurgically excised, localized ocular surface squamous neoplasia. Clin Exp Ophthalmol. 2014;42(4):317–322. doi:10.1111/ceo.1218423927413
  • Parrozzani R, Frizziero L, Trainiti S, et al. Topical 1% 5-fluorouracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101:1094–1099. doi:10.1136/bjophthalmol-2016-30921927941046
  • Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol. 2004;137:950–951. doi:10.1016/j.ajo.2003.10.04815126170
  • Asoklis RS, Damijonaityte A, Butkiene L, et al. Ocular surface reconstruction using amniotic membrane following excision of conjunctival and limbal tumors. Eur J Ophthalmol. 2011;21:552–558. doi:10.5301/EJO.2010.619221188684
  • Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117:2241–2246. doi:10.1016/j.ophtha.2010.03.05220619462
  • Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol. 2008;2:503–515. doi:10.2147/OPTH.S160619668748
  • Gelender H, Forster RK. Papanicolaou cytology in the diagnosis and management of external ocular tumors. Arch Ophthalmol. 1980;98:909–912.6990906
  • Shousha MA, Karp CL, Perez VL, et al. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography. Ophthalmology. 2011;118:1531–1537. doi:10.1016/j.ophtha.2011.01.00521507486
  • Gurung NK, Gautam P, Gurung S, Bhattarai B. Comparison of phacotrabeculectomy and phacotrabeculectomy with subconjunctival 5-Fluorouracil. J Nepal Med Assoc. 2014;52:1010–1013.
  • Vajzovic LM, Karp CL, Haft P, et al. Ultra high-resolution anterior segment optical coherence tomography in the evaluation of anterior corneal dystrophies and degenerations. Ophthalmology. 2011;118:1291–1296.21420175
  • Thomas BJ, Galor A, Nanji AA, et al. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia. Ocul Surf. 2014;12:46–58. doi:10.1016/j.jtos.2013.11.00124439046
  • JoagMG, SiseA, MurilloJC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123:1442–1448. doi:10.1016/j.ophtha.2016.02.03427030104
  • Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000;84:268–272. doi:10.1136/bjo.84.3.26810684836
  • Reynolds JE, Martindale W. Martindale: The Extra Pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society; 1996:572–575.
  • Chaugule SS, Park J, Finger PT. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: is surgery necessary? Indian J Ophthalmol. 2018;66:55–60. doi:10.4103/ijo.IJO_286_1829283124